tirzepatide 15mg/ml GLP-2 TZ – True Lab Peptides Tirzepatide 15mg Vial Dosage Protocol

Participants were randomly assigned to receive Zepbound at 5 mg, 10 mg, 15 mg or placebo once weekly subcutaneously for 72 weeks as an addition to lifestyle modification

The FDA has warned about compounded GLP-1 drugs due to dosing errors, questionable ingredients, and reports of adverse events

The pens contain used needles which are classified as sharps and can pose health risks if not handled correctly

Please note: Due to some factors beyond our control, on rare occasions, delivery times may take longer

To reduce the likelihood of this happening, your healthcare provider may lower your dosage of insulin or oral diabetes meds